Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3

Status Withdrawn

Clinical Trial Summary

This study is to determine whether sleep disorders contribute to impaired quality of life and mobility in patients with Bronchiolitis Obliterans syndrome and whether non invasive positive airways pressure ventilation can improve sleep, quality of life and mobility in this patient group.

Clinical Trial Description

Patients with Bronchiolitis Obliterans syndrome (BOS) 2 & 3 (25) will be matched 1:2 BOS 0 patients with similar demographics such as age, gender, BMI, time post transplant and renal dysfunction.Patients fitting inclusion/exclusion criteria once they have given informed consent will complete questionnaires on quality of life (QOL), any sleep issues they may have and be assessed by a doctor. Data from standard blood tests, respiratory function tests and physio assessments of daytime activity, mobility and muscle strength will be collected. All participants will undergo an overnight sleep study. If a sleep disorder is identified the participant will be offered appropriate treatment. All assessments with the exception of the sleep study will be repeated at 6 and 12 months post sleep study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02109237
Study type	Interventional
Source	The Prince Charles Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	May 2014
Completion date	May 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03603899` - Hp129 Xenon Imaging and BOS in Lung Transplantation	Phase 1/Phase 2
Recruiting	`NCT04098445` - TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Completed	`NCT02441413` - Transplant Optimization Using Functional Imaging (TROFI)	N/A
Recruiting	`NCT02543073` - MSC for Treatment of Interstitial Lung Disease After Allo-HSCT	Phase 1/Phase 2
Terminated	`NCT01432080` - Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant	Phase 2
Recruiting	`NCT00163696` - Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease	N/A
Completed	`NCT00029328` - Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation	Phase 1/Phase 2
Terminated	`NCT01163786` - A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD	Phase 2
Recruiting	`NCT02627833` - Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO	N/A
Completed	`NCT01211509` - Montelukast in Bronchiolitis Obliterans Syndrome	Phase 4
Completed	`NCT01212406` - Vitamin D in Bronchiolitis Obliterans Syndrome	Phase 4
Completed	`NCT00701922` - Surveillance Study of Viral Infections Following Lung Transplantation	N/A
Completed	`NCT00141726` - Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant	Phase 2
Recruiting	`NCT05922761` - BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)	Phase 2
Recruiting	`NCT05881538` - High Intensity Intervallic Training in Children With Bronchiolitis Obliterans	N/A
Terminated	`NCT04655508` - Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation	Phase 3
Completed	`NCT01327248` - Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans	N/A
Recruiting	`NCT05932316` - Evaluating Bronchodilator Response in Patients With Bronchiectasis	N/A
Active, not recruiting	`NCT03656926` - Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)	Phase 3
Completed	`NCT01206309` - Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation	N/A